|
- 2018
The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cellsDOI: 10.1080/15384047.2018.1436024 Keywords: Autophagy, neratinib, niraparib, receptor tyrosine kinase Abstract:
|